BioStreamline project outcomes

CPI have reported successful outcomes the £11.2 million BioStreamline project – a collaborative project involving six partners across the UK including Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery, Alcyomics Ltd and CPI.

The BioStreamline project focused on accelerating monoclonal antibody production and overcoming bottlenecks in biologics manufacturing, with an aim to optimize the discovery and development of cost-effective next generation biotherapeutics.

Key outcomes include:

  • the development of Cyto-Mine® microfluidic picodroplet technology and workflows
  • the expression and purification of more than 50 monoclonal antibodies (mAbs) that have contributed to the design of a developability tool
  • the addition of seven job opportunities at CPI that lead into career pathways in molecular biology

Reflecting on these outcomes, our Vice President of Sales and Marketing, Dr Rob Marchmont stated:

​We are delighted at the outcomes of the BioStreamline project. The development of the Cyto-Mine® platform provides the crucial acceleration needed in monoclonal antibody development and production. Deploying Cyto-Mine® in the biologics area significantly improves efficiencies and reduces timelines in the development workflow and therefore will boost the entry of biologics into the supply chain. Overall this has the potential to have a huge impact on the way biotherapeutics are produced in the UK.”

Dr Rob Marchmont, Vice President of Sales and Marketing, Sphere Fluidics


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sphere Fluidics. (2019, October 16). BioStreamline project outcomes. News-Medical. Retrieved on March 05, 2024 from

  • MLA

    Sphere Fluidics. "BioStreamline project outcomes". News-Medical. 05 March 2024. <>.

  • Chicago

    Sphere Fluidics. "BioStreamline project outcomes". News-Medical. (accessed March 05, 2024).

  • Harvard

    Sphere Fluidics. 2019. BioStreamline project outcomes. News-Medical, viewed 05 March 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Unleashing the Power of Microfluidic Picodroplets